Acute chest pain (ACP) presents a diagnostic challenge for healthcare professionals due to its diverse etiology.
A thorough history, physical examination, and appropriate diagnostic tests are crucial in evaluating ACP. Red flags such as radiation of pain, dyspnea, diaphoresis, and nausea/vomiting should prompt immediate attention.
Conditions such as myocardial infarction, angina, pulmonary embolism, aortic dissection, and pneumothorax should be considered. Non-cardiac causes like gastroesophageal reflux disease and musculoskeletal pain are also common.
Management strategies depend on the underlying cause. For cardiac causes, prompt reperfusion therapy is essential. Non-cardiac causes require appropriate symptomatic treatment.
Understanding the diverse causes of ACP and adopting a comprehensive approach can significantly improve patient outcomes. Ongoing education and clinical vigilance are key in managing this common but potentially life-threatening symptom.
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation